NCT00582634View on ClinicalTrials.gov

Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

docetaxel and cisplatin

Docetaxel (75mg/m2) followed by cisplatin (75mg/m2) on day 1 of a 21 day cycle. Both drugs will be administered intravenously over 1 hour each for4 cycles.

Trial Locations (1)

53792

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT00582634 - Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter